Praram 9 Hospital Public Company Limited Stocks

THB 16.3Last Updated 27.04.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

THB 398.21M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
THB 16.3
Key Takeaways

Risk factor

Low price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Praram 9 Hospital Public Company Limited operates a hospital under the Praram 9 Hospital name in Thailand. The company offers a range of tertiary care services, including health promotion, preventive healthcare, diagnosis, treatment, and rehabilitation in the medical areas of obstetrics and gynecology, surgery, medicine, pediatrics, kidney transplant, cardiovascular, and orthopedics. It also operates diabetes and metabolic, gastroenterology and hepatobiliary, neurology, check-up, emergency, physical therapy and rehabilitation, radiology, eye, ear, nose and throat, dental, mind, skin and cosmetic surgery, breast, joint care, spine, allergy, onco care, sleep, chest and respiratory, wellness, and LASIK centers. The company was founded in 1992 and is based in Bangkok, Thailand.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on EV/EBIT

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of PR9.BK is 28 and suggests 71% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks